D. Faict

发表

Bicarbonate and bicarbonate/lactate peritoneal dialysis solutions for the treatment of infusion pain.

R. Gokal, R. Larsson, R. Mactier, 1998, Kidney international.

Serum transcortin levels in patients with chronic hemodialysis.

P. D. de Moor, R. Verberckmoes, D. Faict, 1985, Annales de biologie clinique.

Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane.

C. Schalkwijk, N. Lameire, A. D. De Vriese, 2004, Kidney international.

A controlled trial of two bicarbonate-containing dialysis fluids for CAPD--final report.

G. Cancarini, R. Gokal, R. Maiorca, 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Stability of Drug Additives in Peritoneal Dialysis Solutions in a New Container

D. Faict, M. Voges, Guy Lechien, 2004, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

A Randomized Clinical Trial with a 0.6% Amino Acid/1.4% Glycerol Peritoneal Dialysis Solution

W. van Biesen, N. Lameire, D. Vijt, 2004, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Acidosis Correction with a new 25 Mmol/L Bicarbonate/15 Mmol/L Lactate Peritoneal Dialysis Solution

D. Faict, J. A. Tomero, Anders Tranæus, 2001, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Peritoneal dialysis solutions inhibit the differentiation and maturation of human monocyte‐derived dendritic cells: effect of lactate and glucose‐degradation products

A. Puig-Kröger, R. Selgas, Á. Corbí, 2003, Journal of leukocyte biology.

Better Preservation of the Peritoneum in Rats Exposed to Amino Acid-Based Peritoneal Dialysis Fluid

J. van den Born, B. Degrève, G. Tangelder, 2005, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Steroid-carrier proteins in patients with multiple myeloma.

P. D. de Moor, G. Vanham, A. Louwagie, 1986, Journal of steroid biochemistry.

Transcortin and alpha 2u-globulin messenger RNA activities during turpentine-induced inflammation in the rat.

P. D. de Moor, G. Verhoeven, D. Faict, 1985, Journal of steroid biochemistry.

Cortisol-free transcortin: preparation and effect on mitogen-stimulated lymphocytes.

P. D. de Moor, J. Ceuppens, W. Heyns, 1983, Journal of steroid biochemistry.

Peritoneal Dialysis Solutions Containing Glycerol and Amino Acids

N. Lameire, D. Faict, 1994, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Contribution of lactate buffer, glucose and glucose degradation products to peritoneal injury in vivo.

C. Schalkwijk, J. van den Born, R. Beelen, 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Intraperitoneal Administration of Drugs in Peritoneal Dialysis Patients: A Review of Compatibility and Guidance for Clinical Use

P. Rutherford, D. Faict, Filip de Vin, 2009, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Effect of two-chambered bicarbonate lactate-buffered peritoneal dialysis fluids on peripheral blood mononuclear cell and polymorphonuclear cell function in vitro.

B. Jaber, B. Pereira, C. Holmes, 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model.

N. Lameire, A. D. De Vriese, S. Mortier, 2005, Kidney international.

Use of monoclonal antibodies in a radioimmunoassay for human transcortin.

P. D. de Moor, D. Faict, 1984, Clinical chemistry.

Peritoneal dialysis solution biocompatibility: definitions and evaluation strategies.

C. Holmes, D. Faict, 2003, Kidney international. Supplement.

Bicarbonate/lactate-based peritoneal dialysis solution increases cancer antigen 125 and decreases hyaluronic acid levels.

R. Krediet, C. Holmes, G. Coles, 2001, Kidney international.

Better preservation of peritoneal morphologic features and defense in rats after long-term exposure to a bicarbonate/lactate-buffered solution.

J. van den Born, R. Beelen, P. T. ter Wee, 2001, Journal of the American Society of Nephrology : JASN.

Clinical Evaluation of a Peritoneal Dialysis Solution with 33 mmol/L Bicarbonate

G. Cancarini, R. Maiorca, D. Faict, 1998, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

In vitro effects of bicarbonate and bicarbonate-lactate buffered peritoneal dialysis solutions on mesothelial and neutrophil function.

C. Holmes, N. Topley, A. Jörres, 1996, Journal of the American Society of Nephrology : JASN.

Continuous dialysis with bicarbonate/lactate-buffered peritoneal dialysis fluids results in a long-term improvement in ex vivo peritoneal macrophage function.

C. Holmes, John D. Williams, G. Coles, 2002, Journal of the American Society of Nephrology : JASN.

In vivo exposure to bicarbonate/lactate- and bicarbonate-buffered peritoneal dialysis fluids improves ex vivo peritoneal macrophage function.

R. Argyle, C. Holmes, G. Coles, 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Bicarbonate/Lactate Dialysis Solution Improves In Vivo Function of Peritoneal Host Defense in Rats

K. Pawlaczyk, C. Holmes, A. Połubińska, 1999, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Bicarbonate/lactate- and bicarbonate-buffered peritoneal dialysis fluids improve ex vivo peritoneal macrophage TNFalpha secretion.

J. Jenkins, C. Holmes, G. Coles, 1998, Journal of the American Society of Nephrology : JASN.

Transcortin modulates the effect of cortisol on mitogen-induced lymphocyte proliferation and immunoglobulin production.

P. D. de Moor, J. Ceuppens, D. Faict, 1985, Journal of steroid biochemistry.

Antibiotic Administration in an Animal Model of Chronic Peritoneal Dialysate Exposure

L. de Ridder, N. Lameire, A. Leyssens, 2003, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

The Effects of Heparin Administration in an Animal Model of Chronic Peritoneal Dialysate Exposure

L. de Ridder, N. Lameire, M. Cornelissen, 2002, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Effects of New Peritoneal Dialysis Solutions on Leukocyte Recruitment in the Rat Peritoneal Membrane

N. Lameire, A. D. De Vriese, S. Mortier, 2005, Nephron Experimental Nephrology.

A Randomized Controlled Trial of a Bicarbonate and a Bicarbonate/Lactate-Containing Dialysis Solution in Capd

R. Gokal, R. Maiorca, G. Coles, 1997, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Reduced Glucose Degradation Products in Bicarbonate/Lactate-Buffered Peritoneal Dialysis Solutions Produced in Two-Chambered Bags

C. Holmes, D. Faict, L. Cooker, 1997, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Effect of Bicarbonate-Based Dialysis Solutions on Intracellular Ph (Phi) and Tnfα Production by Peritoneal Macrophages

A. Douvdevani, B. Rogachev, C. Chaimovitz, 1997, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

In vitro testing of a potentially biocompatible continuous ambulatory peritoneal dialysis fluid.

M. Davies, G. Coles, N. Topley, 1991, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Evaluation of Short-Chain Polypeptides as An Osmotic Agent in Continuous Ambulatory Peritoneal Dialysis Patients

N. Lameire, R. Krediet, A. Imholz, 1994, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

The Use of Peptides in Peritoneal Dialysis Fluids

N. Lameire, R. Krediet, A. Imholz, 1994, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

The in vitro biocompatibility performance of a 25 mmol/L bicarbonate/10 mmol/L lactate-buffered peritoneal dialysis fluid.

A. Dawnay, D. Millar, C. Holmes, 2003, Kidney international. Supplement.

BICARBONATE/LACTATE-BUFFERED PERITONEAL DIAL YSIS SOLUTIONS PRODUCED IN TWO-CHAMBERED BAGS

C. Holmes, D. Faict, L. Cooker, 1997 .

Clinical Experience with a New Bicarbonate (25 Mmol/L)/Lactate (10 Mmol/L) Peritoneal Dialysis Solution

J. Heaf, M. Bajo, H. Dieperink, 2003, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Endoscopic Management of Shoulder Pain in Long-Term Haemodialysis Patients

N. Lameire, D. Faict, D. Kesteloot, 1991 .

Evaluation of peritoneal dialysis solutions with amino acids and glycerol in a rat model.

N. Lameire, F. Peluso, D. Faict, 1991, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Clinical experience with two physiologic bicarbonate/lactate peritoneal dialysis solutions in automated peritoneal dialysis.

P. Rutherford, P. T. ter Wee, M. Wilkie, 2003, Kidney international. Supplement.

Clinical evaluation of an optimized 1.1% amino-acid solution for peritoneal dialysis.

M. Aparicio, F. Peluso, D. Faict, 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Comparison of in vitro AGE formation between standard PD fluid and a novel bicarbonate/lactate formulation.

A. Dawnay, D. Millar, C. Holmes, 1998, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

Insulin Efficacy with a New Bicarbonate/ Lactate Peritoneal Dialysis Solution

P. Williams, G. Coles, D. Faict, 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Use of Monoclonal Antibodies in a Radioimmunoassay for Human

D. Faict, P. De, 2004 .

Compatibility of Insulin over 24 Hours in Standard and Bicarbonate-Based Peritoneal Dialysis Solutions Contained in Bags Made of Different Materials

J. Divino-Filho, D. Faict, F. Somers, 2006, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Phylogenetic study of transcortin using monoclonal antibodies.

P. D. de Moor, D. Faict, 1986, Biochemical and biophysical research communications.

Further data on the association of unexplained high transcortin levels with lymphoproliferative malignancies on the one hand and certain HLA haplotypes on the other hand.

P. D. de Moor, A. Louwagie, D. Faict, 1983, Acta Clinica Belgica.

Response of transcortin and alpha 2u-globulin to turpentine-induced inflammation in the rat: influence of corticosteroids and prolactin.

E. Lesaffre, P. D. de Moor, G. Verhoeven, 1983, The Journal of endocrinology.